129 related articles for article (PubMed ID: 29753273)
1. Generation of an induced pluripotent stem cell line from a patient with non-syndromic CLN3-associated retinal degeneration and a coisogenic control line.
Zhang X; Zhang D; Chen SC; Lamey T; Thompson JA; McLaren T; De Roach JN; Chen FK; McLenachan S
Stem Cell Res; 2018 May; 29():245-249. PubMed ID: 29753273
[TBL] [Abstract][Full Text] [Related]
2. Generation of an induced pluripotent stem cell line from a patient with retinitis pigmentosa caused by RP1 mutation.
Zhang X; Moon SY; Zhang D; Chen SC; Lamey T; Thompson JA; McLaren T; De Roach JN; McLenachan S; Chen FK
Stem Cell Res; 2019 May; 37():101452. PubMed ID: 31059986
[TBL] [Abstract][Full Text] [Related]
3. Establishment of an induced pluripotent stem cell line from a retinitis pigmentosa patient with compound heterozygous CRB1 mutation.
Zhang X; Zhang D; Chen SC; Lamey T; Thompson JA; McLaren T; De Roach JN; Chen FK; McLenachan S
Stem Cell Res; 2018 Aug; 31():147-151. PubMed ID: 30092450
[TBL] [Abstract][Full Text] [Related]
4. Generation of a human iPSC line from a patient with retinitis pigmentosa caused by mutation in PRPF8 gene.
Lukovic D; Bolinches-Amorós A; Artero-Castro A; Pascual B; Carballo M; Hernan I; Erceg S
Stem Cell Res; 2017 May; 21():23-25. PubMed ID: 28677533
[TBL] [Abstract][Full Text] [Related]
5. Gene correction of the CLN3 c.175G>A variant in patient-derived induced pluripotent stem cells prevents pathological changes in retinal organoids.
Zhang X; Zhang D; Thompson JA; Chen SC; Huang Z; Jennings L; McLaren TL; Lamey TM; De Roach JN; Chen FK; McLenachan S
Mol Genet Genomic Med; 2021 Mar; 9(3):e1601. PubMed ID: 33497524
[TBL] [Abstract][Full Text] [Related]
6. Generation of the induced pluripotent stem cell line from a patient with autosomal recessive ABCA4-mediated Stargardt Macular Dystrophy.
Claassen JN; Zhang D; Chen SC; Moon SY; Lamey T; Thompson JA; McLaren T; De Roach JN; McLenachan S; Chen FK
Stem Cell Res; 2019 Jan; 34():101352. PubMed ID: 30634128
[TBL] [Abstract][Full Text] [Related]
7. Using Patient-Specific Induced Pluripotent Stem Cells and Wild-Type Mice to Develop a Gene Augmentation-Based Strategy to Treat CLN3-Associated Retinal Degeneration.
Wiley LA; Burnight ER; Drack AV; Banach BB; Ochoa D; Cranston CM; Madumba RA; East JS; Mullins RF; Stone EM; Tucker BA
Hum Gene Ther; 2016 Oct; 27(10):835-846. PubMed ID: 27400765
[TBL] [Abstract][Full Text] [Related]
8. Generation of two induced pluripotent stem cell lines from a patient with recessive inherited retinal disease caused by compound heterozygous mutations in SNRNP200.
Zhang D; McLenachan S; Chen SC; Zaw K; Alziyadat Y; Zhang X; Lamey TM; Thompson JA; McLaren TL; Mellough C; De Roach JN; Chen FK
Stem Cell Res; 2021 Mar; 51():102154. PubMed ID: 33429167
[TBL] [Abstract][Full Text] [Related]
9. Generation of two induced pluripotent stem cell lines from a patient with dominant PRPF31 mutation and a related non-penetrant carrier.
McLenachan S; Zhang D; Zhang X; Chen SC; Lamey T; Thompson JA; McLaren T; De Roach JN; Fletcher S; Chen FK
Stem Cell Res; 2019 Jan; 34():101357. PubMed ID: 30611018
[TBL] [Abstract][Full Text] [Related]
10. Generation of two induced pluripotent stem cell lines from a patient with compound heterozygous mutations in the USH2A gene.
McLenachan S; Wong EYM; Zhang X; Leith F; Moon SY; Zhang D; Chen SC; Thompson JA; McLaren T; Lamey T; De Roach JN; Atlas MD; Dilley RJ; Chen FK
Stem Cell Res; 2019 Apr; 36():101420. PubMed ID: 30904819
[TBL] [Abstract][Full Text] [Related]
11. Generation of induced pluripotent stem cell line (ZZUi0012-A) from a patient with Fahr's disease caused by a novel mutation in SLC20A2 gene.
Zhang Q; Li Z; Sun H; Zhang S; Zhang J; Wang Y; Fang H; Xu Y
Stem Cell Res; 2019 Mar; 35():101395. PubMed ID: 30776674
[TBL] [Abstract][Full Text] [Related]
12. Generation of induced pluripotent stem cell line (ZZUi0014-A) from a patient with spinocerebellar ataxia type 3.
Wang Y; Sun H; Wang Z; Yue Y; Zhang R; Yang J; Liu Y; Liu H; Zhang Q; Zhang S; Zhang J; Xu Y; Shi C
Stem Cell Res; 2019 Dec; 41():101564. PubMed ID: 31639609
[TBL] [Abstract][Full Text] [Related]
13. Generation of a human induced pluripotent stem cell line CERAi001-A-6 using episomal vectors.
Wong RCB; Hung SS; Jackson S; Singh V; Khan S; Liang HH; Kearns LS; Nguyen T; Conquest A; Daniszewski M; Hewitt AW; Pébay A
Stem Cell Res; 2017 Jul; 22():13-15. PubMed ID: 28952926
[TBL] [Abstract][Full Text] [Related]
14. Generation of induced pluripotent stem cell (iPSC) line from a 36-year-old Charcot-Marie-Tooth disease patient with GJB1 mutation (CMTX).
Son D; Kang PJ; Yun W; You S
Stem Cell Res; 2017 May; 21():9-12. PubMed ID: 28677541
[TBL] [Abstract][Full Text] [Related]
15. Generation of two induced pluripotent stem cell lines from a patient with Stargardt Macular Dystrophy caused by the c.768G>T and c.6079C>T mutations in ABCA4.
Jennings L; Zhang D; Chen SC; Moon SY; Lamey T; Thompson JA; McLaren T; De Roach JN; Chen FK; McLenachan S
Stem Cell Res; 2020 Oct; 48():101947. PubMed ID: 32810830
[TBL] [Abstract][Full Text] [Related]
16. Derivation of an induced pluripotent stem cell line (MUSIi004-A) from dermal fibroblasts of a 48-year-old spinocerebellar ataxia type 3 patient.
Ritthaphai A; Wattanapanitch M; Pithukpakorn M; Heepchantree W; Soi-Ampornkul R; Mahaisavariya P; Triwongwaranat D; Pattanapanyasat K; Vatanashevanopakorn C
Stem Cell Res; 2018 Jul; 30():113-116. PubMed ID: 29852467
[TBL] [Abstract][Full Text] [Related]
17. Generation of two induced pluripotent stem cell lines from a retinitis pigmentosa patient with compound heterozygous mutations in CRB1.
Moon SY; Zhang D; Chen SC; Lamey TM; Thompson JA; McLaren TL; De Roach JN; Chen FK; McLenachan S
Stem Cell Res; 2021 Jul; 54():102403. PubMed ID: 34034222
[TBL] [Abstract][Full Text] [Related]
18. Detailed Clinical Phenotype and Molecular Genetic Findings in CLN3-Associated Isolated Retinal Degeneration.
Ku CA; Hull S; Arno G; Vincent A; Carss K; Kayton R; Weeks D; Anderson GW; Geraets R; Parker C; Pearce DA; Michaelides M; MacLaren RE; Robson AG; Holder GE; Heon E; Raymond FL; Moore AT; Webster AR; Pennesi ME
JAMA Ophthalmol; 2017 Jul; 135(7):749-760. PubMed ID: 28542676
[TBL] [Abstract][Full Text] [Related]
19. Generation of an induced pluripotent stem cell line (FRIMOi002-A) from a retinitis pigmentosa patient carrying compound heterozygous mutations in USH2A gene.
Riera M; Patel A; Corcostegui B; Chang S; Corneo B; Sparrow JR; Pomares E
Stem Cell Res; 2019 Mar; 35():101386. PubMed ID: 30685615
[TBL] [Abstract][Full Text] [Related]
20. Lymphoblast-derived integration-free iPSC line AD-TREM2-3 from a 74 year-old Alzheimer's disease patient expressing the TREM2 p.R47H variant.
Martins S; Yigit H; Bohndorf M; Graffmann N; Fiszl AR; Wruck W; Sleegers K; Van Broeckhoven C; Adjaye J
Stem Cell Res; 2018 Jul; 30():141-144. PubMed ID: 29902745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
